{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:29:28Z","timestamp":1787160568113,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002418","name":"China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica","doi-asserted-by":"publisher","award":["037GJHZ2023043FN"],"award-info":[{"award-number":["037GJHZ2023043FN"]}],"id":[{"id":"10.13039\/501100002418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["24RCKA007"],"award-info":[{"award-number":["24RCKA007"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["23JRRA623"],"award-info":[{"award-number":["23JRRA623"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["23ZDNA002"],"award-info":[{"award-number":["23ZDNA002"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["23ZYQK0001"],"award-info":[{"award-number":["23ZYQK0001"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmcl.2025.130443","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:03Z","timestamp":1761059283000},"page":"130443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel HIF-1\u03b1 PROTACs degrader as potent anti-cervical cancer agents"],"prefix":"10.1016","volume":"131","author":[{"given":"En-Jie","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Sheng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Sheng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharcisse","family":"Gatera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130443_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/sni.sni_111_17","article-title":"Cervical cancer metastasis to the brain: a case report and review of literature","volume":"8","author":"Fetcko","year":"2017","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.bmcl.2025.130443_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2025.130443_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/1568009623666230817105221","article-title":"Research Progress of neural invasion in pancreatic Cancer","volume":"24","author":"Zhu","year":"2024","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.bmcl.2025.130443_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcancer.2023.11.001","article-title":"Hypoxia signaling and metastatic progression","volume":"97","author":"Schito","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s11658-024-00682-7","article-title":"Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer","volume":"30","author":"Zhang","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.bmcl.2025.130443_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0955-0674(00)00194-0","article-title":"HIF-1 and mechanisms of hypoxia sensing","volume":"13","author":"Semenza","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0035","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/mol.106.027029","article-title":"Hypoxia-inducible factor-1 (HIF-1)","volume":"70","author":"Ke","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091854","article-title":"Targeting tumor adaption to chronic hypoxia: implications for drug resistance, and how it can be overcome","volume":"18","author":"Kim","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130443_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115703","article-title":"Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130443_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2025.130443_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115235","article-title":"Small molecules targeting HIF-1\u03b1 pathway for cancer therapy in recent years","volume":"28","author":"Tang","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2025.130443_bb0060","article-title":"Therapeutic targeting of hypoxia-inducible factors in Cancer","volume":"25","author":"Din","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130443_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1592\/phco.23.2.165.32088","article-title":"2-Methoxyestradiol, a promising anticancer agent","volume":"23","author":"Lakhani","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bmcl.2025.130443_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108371","article-title":"Novel strategies and promising opportunities for targeted protein degradation: an innovative therapeutic approach to overcome cancer resistance","volume":"244","author":"Zhu","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2025.130443_bb0090","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2025.130443_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2025.130443_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116096","article-title":"Progress in the controllability technology of PROTAC","volume":"265","author":"He","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130443_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107943","article-title":"Discovery of potent hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) degraders by proteolysis targeting chimera (PROTAC)","volume":"153","author":"Li","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130443_bb0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bcp.2010.06.018","article-title":"LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line","volume":"80","author":"Lee","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0115","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1002\/anie.201304987","article-title":"Identification of malate dehydrogenase 2 as a target protein of the HIF-1 inhibitor LW6 using chemical probes","volume":"52","author":"Lee","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130443_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175154","article-title":"The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1\u03b1\/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo","volume":"930","author":"Xu","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","article-title":"Peptide-drug conjugates with different linkers for Cancer therapy","volume":"64","author":"Alas","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130443_bb0150","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2174\/1871520618666180605082026","article-title":"Cytotoxic and apoptotic effects of novel Pyrrolo[2,3-d]pyrimidine derivatives containing urea moieties on Cancer cell lines","volume":"18","author":"Kilic-Kurt","year":"2018","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.bmcl.2025.130443_bb0155","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1111\/cas.15890","article-title":"Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: current understanding and future directions","volume":"114","author":"Sato","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bmcl.2025.130443_bb0160","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschembio.3c00199","article-title":"Reversible assembly of proteolysis targeting chimeras","volume":"18","author":"Gui","year":"2023","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0165","first-page":"78","article-title":"Lessons in PROTAC design from selective degradation with a promiscuous warhead, cell","volume":"25","author":"Bondeson","year":"2018","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0170","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2025.130443_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0092-8674(95)90241-4","article-title":"Multiple proteolytic systems, including the proteasome, contribute to CFTR processing","volume":"83","author":"Jensen","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2025.130443_bb0180","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1002\/anie.201307761","article-title":"Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system","volume":"53","author":"Buckley","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2025.130443_bb0185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.biopha.2017.10.020","article-title":"Tretinoin-loaded lipid-core nanocapsules overcome the triple-negative breast cancer cell resistance to tretinoin and show synergistic effect on cytotoxicity induced by doxorubicin and 5-fluororacil","volume":"96","author":"Schultze","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2025.130443_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noac200.066","article-title":"Treatment response in GBM cells under normoxic and hypoxic conditions","volume":"24","author":"Griggs","year":"2022","journal-title":"Neuro-Oncology."},{"key":"10.1016\/j.bmcl.2025.130443_bb0195","doi-asserted-by":"crossref","first-page":"15628","DOI":"10.1074\/jbc.273.25.15628","article-title":"Dissociation of phagocyte recognition of cells undergoing apoptosis from other features of the apoptotic program","volume":"273","author":"Zhuang","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130443_bb0200","article-title":"Integrating multi-omics and experimental techniques to decode ubiquitinated protein modifications in hepatocellular carcinoma","volume":"16","author":"Yang","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130443_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.514","article-title":"Dual blocking of PI3K and mTOR signaling by DHW-221, a novel benzimidazole derivative, exerts antitumor activity in human non-small cell lung cancer","volume":"11","author":"Qin","year":"2021","journal-title":"Clin Transl Med"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500352X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500352X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:35:32Z","timestamp":1780914932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2500352X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S0960894X2500352X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130443","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel HIF-1\u03b1 PROTACs degrader as potent anti-cervical cancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130443"}}